Esperion Therapeutics Inc’s recent filing unveils that its Chief Commercial Officer Warren Eric unloaded Company’s shares for reported $227.0 on Oct 17 ’24. In the deal valued at $2.12 per share,107 shares were sold. As a result of this transaction, Warren Eric now holds 162,552 shares worth roughly $0.33 million.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, Warren Eric bought 107 shares, generating $227 in total proceeds.
Before that, Koenig Sheldon L. sold 14,550 shares. Esperion Therapeutics Inc shares valued at $26,132 were divested by the President and CEO at a price of $1.80 per share. As a result of the transaction, Koenig Sheldon L. now holds 752,266 shares, worth roughly $1.5 million.
BofA Securities downgraded its Esperion Therapeutics Inc [ESPR] rating to an Underperform from a a Neutral in a research note published recently. A number of analysts have revised their coverage, including BofA Securities’s analysts, who decreased its forecast for the stock in early January from “a Buy” to “a Neutral”. Northland Capital revised its rating on August 01, 2023. It rated ESPR as “a Market perform” which previously was an “an Under perform”.
Price Performance Review of ESPR
On Monday, Esperion Therapeutics Inc [NASDAQ:ESPR] saw its stock fall -1.48% to $2.00. Over the last five days, the stock has lost -6.10%. Esperion Therapeutics Inc shares have fallen nearly -33.11% since the year began. Nevertheless, the stocks have risen 126.24% over the past one year. While a 52-week high of $3.40 was reached on 04/08/24, a 52-week low of $0.85 was recorded on 10/02/24. SMA at 50 days reached $1.88, while 200 days put it at $2.21.
Levels Of Support And Resistance For ESPR Stock
The 24-hour chart illustrates a support level at 1.96, which if violated will result in even more drops to 1.93. On the upside, there is a resistance level at 2.04. A further resistance level may holdings at 2.09. The Relative Strength Index (RSI) on the 14-day chart is 49.57, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.05, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 89.66%. Stochastics %K at 17.74% indicates the stock is a buying.
How much short interest is there in Esperion Therapeutics Inc?
A steep rise in short interest was recorded in Esperion Therapeutics Inc stocks on 2024-10-15, dropping by -2.7 million shares to a total of 35.39 million shares. Yahoo Finance data shows the prior-month short interest on 2024-09-13 was 38.09 million shares. There was a decline of -7.64%, which implies that there is a negative sentiment for the stock.
